| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |